
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 6195, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1657 |
| Total Applications | 627 |
| Issued Applications | 269 |
| Pending Applications | 52 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5279228
[patent_doc_number] => 20090131360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Tripartite RNAi constructs'
[patent_app_type] => utility
[patent_app_number] => 12/286896
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16912
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131360.pdf
[firstpage_image] =>[orig_patent_app_number] => 12286896
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286896 | Tripartite RNAi constructs | Oct 1, 2008 | Abandoned |
Array
(
[id] => 7683675
[patent_doc_number] => 20100240736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use'
[patent_app_type] => utility
[patent_app_number] => 12/681590
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10453
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240736.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681590
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681590 | Compounds for the treatment or alleviation of edema, and methods for their use | Oct 1, 2008 | Issued |
Array
(
[id] => 6527731
[patent_doc_number] => 20100203627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'LONG-TERM IN VIVO TRANSGENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/676426
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17703
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676426 | Long-term in vivo transgene expression | Sep 11, 2008 | Issued |
Array
(
[id] => 5585977
[patent_doc_number] => 20090105179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'DRUG CARRIERS'
[patent_app_type] => utility
[patent_app_number] => 12/210098
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18753
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12210098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/210098 | Drug carriers | Sep 11, 2008 | Issued |
Array
(
[id] => 6328340
[patent_doc_number] => 20100197765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'METHOD FOR PROMOTING THE EXPRESSION OF P53, AND P53 EXPRESSION PROMOTER FOR USE IN THE METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/676443
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 33902
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676443 | METHOD FOR PROMOTING THE EXPRESSION OF P53, AND P53 EXPRESSION PROMOTER FOR USE IN THE METHOD | Sep 4, 2008 | Abandoned |
Array
(
[id] => 5290421
[patent_doc_number] => 20090023151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Method For The Labeling And Detection Of Small Polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 12/202133
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13702
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12202133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/202133 | Method For The Labeling And Detection Of Small Polynucleotides | Aug 28, 2008 | Abandoned |
Array
(
[id] => 10608322
[patent_doc_number] => 09328345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-03
[patent_title] => 'Compositions of asymmetric interfering RNA and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/199797
[patent_app_country] => US
[patent_app_date] => 2008-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 29
[patent_no_of_words] => 25436
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12199797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/199797 | Compositions of asymmetric interfering RNA and uses thereof | Aug 26, 2008 | Issued |
Array
(
[id] => 6378610
[patent_doc_number] => 20100081706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'IMMUNOMODULATORY OLIOGONUCLEOTIDES AND METHODS OF USE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/185418
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14692
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185418 | Immunomodulatory oligonucleotides and methods of use therefor | Aug 3, 2008 | Issued |
Array
(
[id] => 5310818
[patent_doc_number] => 20090018099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/184626
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25270
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184626 | PROTEIN PRODUCTION | Jul 31, 2008 | Abandoned |
Array
(
[id] => 5336742
[patent_doc_number] => 20090053206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'NOVEL SYNTHETIC AGONISTS OF TLR9'
[patent_app_type] => utility
[patent_app_number] => 12/183439
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 10619
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053206.pdf
[firstpage_image] =>[orig_patent_app_number] => 12183439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/183439 | Synthetic agonists of TLR9 | Jul 30, 2008 | Issued |
Array
(
[id] => 5508583
[patent_doc_number] => 20090081790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Polynucleotide for Target Gene'
[patent_app_type] => utility
[patent_app_number] => 12/182499
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18833
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182499 | Polynucleotide for Target Gene | Jul 29, 2008 | Abandoned |
Array
(
[id] => 5564657
[patent_doc_number] => 20090137510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/171034
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 69041
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137510.pdf
[firstpage_image] =>[orig_patent_app_number] => 12171034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/171034 | RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Jul 9, 2008 | Abandoned |
Array
(
[id] => 5952630
[patent_doc_number] => 20110033547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'DEHYDRATED CHITOSAN NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/667204
[patent_app_country] => US
[patent_app_date] => 2008-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6578
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033547.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667204
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667204 | DEHYDRATED CHITOSAN NANOPARTICLES | Jul 3, 2008 | Abandoned |
Array
(
[id] => 5297104
[patent_doc_number] => 20090012030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 12/165705
[patent_app_country] => US
[patent_app_date] => 2008-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11215
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012030.pdf
[firstpage_image] =>[orig_patent_app_number] => 12165705
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/165705 | RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION | Jun 30, 2008 | Abandoned |
Array
(
[id] => 6577614
[patent_doc_number] => 20100273855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/666253
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22368
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666253 | COMPOSITIONS AND METHODS OF TREATING CANCER | Jun 25, 2008 | Abandoned |
Array
(
[id] => 10018540
[patent_doc_number] => 09061009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Mixed lineage kinases and metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 12/663436
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 37
[patent_no_of_words] => 17753
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663436
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663436 | Mixed lineage kinases and metabolic disorders | Jun 8, 2008 | Issued |
Array
(
[id] => 8749265
[patent_doc_number] => 08415096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Micro-RNAs modulating immunity and inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/600803
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 32
[patent_no_of_words] => 17214
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600803
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600803 | Micro-RNAs modulating immunity and inflammation | May 22, 2008 | Issued |
Array
(
[id] => 4779668
[patent_doc_number] => 20080287666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'DETECTING NUCLEIC ACID STRANDS AND INTER-SUBSTANCE BINDING OR INTERACTION DETECTING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/120119
[patent_app_country] => US
[patent_app_date] => 2008-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5737
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287666.pdf
[firstpage_image] =>[orig_patent_app_number] => 12120119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/120119 | DETECTING NUCLEIC ACID STRANDS AND INTER-SUBSTANCE BINDING OR INTERACTION DETECTING METHOD | May 12, 2008 | Abandoned |
Array
(
[id] => 6249392
[patent_doc_number] => 20100137407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/598974
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5948
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598974
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598974 | SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME | May 8, 2008 | Abandoned |
Array
(
[id] => 8398411
[patent_doc_number] => 08268793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'RNA antagonist compounds for the modulation of HER3'
[patent_app_type] => utility
[patent_app_number] => 12/118271
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 25795
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12118271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118271 | RNA antagonist compounds for the modulation of HER3 | May 8, 2008 | Issued |